- It's week 5 of the lockdown. The world has changed at so many fundamental levels, that is the accepted datapoint, but has it really?
- In the past 5 weeks, these happened:
- At a global level (i) US under Trump has been exposed like the incompetent leader that he is, the UK is not too far behind. (BoJo, sorry for your Covid-19 affliction, sir, but your country is in really bad shape now); (ii) China has taken charge of the narrative from being the source of the virus through unhygienic and questionable dietary choices; to leading the world to how to handle a crisis and extending soft power diplomacy to many developed / developing nations in dire need of help, (iii) the rise of pharmas, biotechs and VC tech companies to combat the dangerous and cunning virus (iv) healthcare delivery systems in developed worlds overwhelmed by Covid cases;
- At a national level (i) schools / universities closed down and students intakes for next year to traditional establishments has been cast into uncertain limbo, not to mention teachers taking on additional workloads (ii) SMEs getting severely and adversely affected by the lockdown - at least 6 weeks and eating into traditionally high retail seasons (iii) businesses pausing and restrategising where the world is headed to - a digital transition where applicable, (iv) adjusting to possibility of further economic impact in a world of intermittent lockdowns (v) financial stimulus opportunities abound.
- Nationally, any politicking is on pause. Which is a benefit.
- At family levels, the salary earners will need to consider how to bring in the dosh. How best to adapt in this strange, unpredictable world.
- Commentary is only there for therapeutic reasons - it is a world that appears to need to be rebuilt brick-by-brick.
- Some thoughts, just for posterity:
- Care protocols for Covid-19 is being updated almost daily, and the US due to the sheer case volume is unfortunately, the best place to research.
- Vaccine development is just so far away - as it stands, only Moderna's first RNA solution is entering into Phase 1 in, I don't know, the first 2 patients? Even in best case, it will be 12 months away, notwithstanding potential manufacturing bottlenecks to do method transfer of its new process manufacture. And without a vaccine, the physical distancing measures is the only way to prevent continual recurrence of the outbreak that can overwhelm hospital care capacity in a matter of weeks.
- With intermittent lockdowns appearing to be a new status quo in the near to mid-term future, the economic effects will not be sparing but can only be mitigated. Without an adaptive solution, we will not be prepared.
- Obvious solution is extensive detection (rt-pcr) and immunity (serological) testing and contact tracing. Our execution capacity to do this is questionable - even in the best cases scenario as proposed by some very brash voices, I doubt we will be able to do this at scale.
- The benefits of convalescent plasma arising from serological tests appear to be lofty ideals at the moment - do we have the scale for purification and acceptance at our end at the economic costs we have? Is it still cheaper to do with primary care and ensuring our capacity is not overwhelmed at the most dangerous spikes?
- The economic impact is one where the biggest opportunities will lie. There is an abstraction of needs that will probably be filled by the Apples and Googles, but the need for a local solution I believe will be overwhelming.
- Digitisation of verification, processes, marketing, conferencing; medical devices and solutions that enhance efficiencies of healthcare delivery systems are almost inevitable in the shortest possible timeframe. The introduction of these solutions at a freemium initiation and building up loyalty over the next difficult phase of the Covid fight will probably be the best position.
10. I should change for the better. If anything, to have a cunning, invisible, microscopic piece of single-stranded "organism" causing this much havoc on the planet is extremely humbling. If only the world takes heed.
No comments:
Post a Comment